Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
2025/12/02

DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slid 3.08% to $22.69 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.38% to 23,275.92 and Dow Jones Industrial Average falling 0.90% to 47,289.33.

This was the stock's third consecutive day of losses.

Catalyst Pharmaceuticals Inc. closed 14.64% below its 52-week high of $26.58, which the company reached on June 9th.

The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.76% to $205.34, Pfizer Inc. $(PFE)$ fell 1.83% to $25.27, and Abbott Laboratories $(ABT)$ fell 0.69% to $128.01.

Trading volume (1.2 M) remained 227,931 below its 50-day average volume of 1.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 01, 2025 17:22 ET (22:22 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10